
-

Safety Reports Analyzed with A.I. to Reduce Medical Errors
Research is underway to write algorithms for analyzing free text and other unstructured data in safety report databases to reduce medical errors.
-

Spray Fiber Process Designed for Wound Bandages
An engineering team created a portable device that in lab tests sprays bio-compatible fibers on simulated wound surfaces to promote healing.
-

Digital Meds Boost Hepatitis C Drug Adherence
A system with electronic sensors added to pills helps people known to skip taking medications stick with their drugs prescribed for hepatitis C.
-

Liquid Injectable Electrodes Designed for Nerve Stimulation
In lab animal tests, an injectable silicon-metal material performs as well as conventional electrodes for electrical nerve stimulation, an emerging therapy for pain.
-

New Company Using A.I. to Discover Mental Health Drugs
A new enterprise combining resources from biotechnology and artificial intelligence aims to find safer and more effective treatments for psychiatric disorders.
-

Opioids Provide Few Pain Benefits, Yet Abuse Growing
Opioids appear to provide little benefit for patients with pain from osteoarthritis, yet opioid use disorder rates among patients with painful conditions continue to rise.
-

Infographic – Q3 A.I. Health Investments Set Record
Venture capital funding for companies worldwide building artificial intelligence solutions in health care set new highs in the third quarter of 2019.
-

Phone-Based Infectious Disease Diagnostics Being Developed
An engineering lab is building a system for diagnosing viral infectious diseases with blood samples analyzed by a smartphone add-on.
-

Artificial Kidney Component Passes Preclinical Test
A miniaturized bio-electronic device implanted in a pig can process filtered blood like a real kidney without triggering an immune response or blood clots.
-

Engineered Organ Transplant Company Raises New Funds
An enterprise that applies gene editing to create replacement organs from pigs for human transplant is raising $100 million in new venture financing.